Follow The Filings

KYMR Kymera Therapeutics Inc.

Health Care, filed as KYMERA THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 2 Owners
  • Max 0.6%
  • $5.4M
  • 1 new

In 2026 Q2 Nathan Fischel opened a position in Kymera Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.6% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel New 0.59%

Who owns KYMR

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.59% New 0.59% 27,000 $3.1M History
Ron Baron, Bamco Inc. (Baron Capital) <0.01% Hold 20,000 $2.3M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by KYMR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KYMR insider trades
  • $172M bought by 1 insider
  • $195M sold by 2 insiders outside a trading plan
  • $267M sold by 9 insiders under 10b5-1 plans
  1. Nello Mainolfi CEO
    Planned sale
    $3.4M 30,000 shares at $113.80 4.3% of stake
    Traded Oct 1 Filed Oct 1
    ↗
  2. Nello Mainolfi CEO
    Planned sale
    $6M 50,000 shares at $119.00 7% of stake
    Traded Jul 7 Filed Jul 7
    ↗
  3. Bruce Booth Director
    Planned sale
    $8.3M 76,650 shares at $108.05 14% of stake
    Traded Jun 29 Filed Jul 2
    ↗
  4. Bruce N. Jacobs CFO
    Planned sale
    $8.9M 77,109 shares at $114.96 24% of stake
    Traded Jun 30 Filed Jul 2
    ↗
  5. Noah Goodman Chief Business Officer
    Planned sale
    $387K 3,389 shares at $114.29 6.7% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  6. Nello Mainolfi CEO
    Planned sale
    $9.2M 80,000 shares at $115.29 11% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  7. Bruce Booth Director
    Planned sale
    $51.6M 467,878 shares at $110.29 50% of stake
    Traded Jun 26 Filed Jun 30
    ↗
  8. Bvf Partners L P Director, +9 joint filers
    Sale
    $174M 1,630,658 shares at $106.50
    Traded Jun 26 Filed Jun 26
    ↗
  9. Bruce Booth Director
    Planned sale
    $34.8M 285,684 shares at $121.86 35% of stake
    Traded Jun 25 Filed Jun 25
    ↗
  10. Bruce Booth Director
    Planned sale
    $44M 398,765 shares at $110.31 41% of stake
    Traded Jun 23–25 Filed Jun 25
    ↗
  11. Noah Goodman Chief Business Officer
    Planned sale
    $570K 5,000 shares at $114.00 9.1% of stake
    Traded Jun 25 Filed Jun 25
    ↗
  12. Bruce Booth Director
    Planned sale
    $3.3M 31,798 shares at $103.75 4.9% of stake
    Traded Jun 22 Filed Jun 22
    ↗
  13. Bruce Booth Director
    Planned sale
    $45.3M 478,198 shares at $94.72
    Traded Jun 17–22 Filed Jun 22
    ↗
  14. Noah Goodman Chief Business Officer
    Planned sale
    $248K 2,500 shares at $99.00 4.7% of stake
    Traded Jun 22 Filed Jun 22
    ↗
  15. Jeremy G Chadwick COO
    Planned sale
    $1.1M 13,130 shares at $80.38 23% of stake
    Traded May 26–27 Filed May 27
    ↗

Also filed in the last 12 months, not counted as buying or selling: 44 option exercises, 28 sales to cover taxes, and 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $78.59M $47.07M $39.21M
Gross profit * — $0.00 $0.00
Gross margin * — 0.0% 0.0%
Net income -$146.96M -$223.86M -$311.35M
Net margin * -187.0% -475.6% -794.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $405.32M $510.27M $871.21M
Total non-current assets * $170.44M $467.77M $871.6M
Total assets $0.576B $0.978B $1.74B
Total current liabilities $85.69M $67.77M $83.21M
Total non-current liabilities * $95.1M $74.65M $79.94M
Total equity $0.395B $0.836B $1.58B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$102.83M -$194.5M -$232.89M
Cash from investing $139.89M -$404.08M -$521.06M
Cash from financing $4.19M $608.85M $990.71M
Net change in cash $41.25M $10.27M $236.76M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.